Hidding, Ute http://orcid.org/0000-0001-8016-1821
Mainka, Tina http://orcid.org/0000-0002-0597-2648
Buhmann, Carsten http://orcid.org/0000-0001-8540-3789
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 10 September 2023
Accepted: 31 October 2023
First Online: 28 November 2023
Declarations
:
: The authors declare that they were not guided by any economic interests when creating the article. TM is supported by the BIH-Charité Clinician Scientist Program of the Charité-Universitätsmedizin Berlin and the Berlin Institute of Health. She has received author fees from Elsevier and Urban & Fischer, lecture fees from Stadapharm and BIAL and has served on the Advisory Board of Biomarin Pharmaceutical. CB has received author fees from Kohlhammer, Springer and Thieme, advisory board fees from Stadapharm and Zambon, and speaking honoraria from AbbVie, Abbott, BIAL, Hormosan, and Zambon.